Device Trial Radar · NCT04040387
NightWare Randomized Trial 02
Last checked: Nov 19, 2026Latest source record: Apr 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
270
Actual
Start
Jul 24, 2019
Primary completion
May 31, 2025
Study completion Aug 2, 2025
Sponsor
- Lead sponsor
- NightWareNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Minneapolis Veterans Affairs Medical Center; Louis Stokes VA Medical Center; Walter Reed National Military Medical Center; Ralph H. Johnson VA Medical Center
- First posted
- Jul 31, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will provide preliminary estimates of safety and efficacy of the NightWare digital therapeutic system (iPhone + Apple watch + proprietary application) for the treatment of nightmare disorder associated with post-traumatic stress disorder (PTSD)-related sleep disturbance and the impact of improved sleep with the NightWare digital therapeutic system. The investigators hypothesize that the NightWare digital therapeutic system will significantly improve sleep quality in participants with PTSD-Related nightmares and poor sleep quality.
Conditions
- Stress Disorders, Post-Traumatic
- Combat Disorders
- Ptsd
- Nightmare
- Nightmares, REM-Sleep Type
- Nightmare Disorder With Associated Non-Sleep Disorder
Interventions
NightWare Therapeutic SystemDevice
A wearable digital therapeutic system that will measure physiologic data when worn during sleep to deliver a mild vibration via the watch to elicit arousal thereby disrupting nightmares. This detection and stimulation sequence will be performed according to NightWare's proprietary algorithm.
Sham NightWareDevice
NightWare device not providing interventions
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in global score on the Pittsburgh Sleep Quality Index (PSQI) from Day 0 to Day 30Time frame: 0-90 days
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Walter Reed National Military Medical Center
Bethesda, Maryland
Minneapolis VA Healthcare System
Minneapolis, Minnesota
Louis Stokes Cleveland VA Medical Center
Cleveland, Ohio
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.